The possibility that preexisting specific serum antibody could suppress a defined mucosal immune response to a topically applied antigen was studied in rats. Hyperimmune serum antibody induced by parenteral immunization of rats with cholera toxoid markedly suppressed the mucosal immune response to enterically applied cholera toxin. Such antibody was far more suppressive than antibody induced by primary parenteral immunization, apparently due to its greater avidity. Transfusion of small amounts (25 to 100 pi) of hyperimmune serum suppressed the primary mucosal antitoxin response, the development of specific memory in the mucosal immune system, and, somewhat less effectively, the secondary mucosal antitoxin response. Suppression was due largely to a direct effect of serum antibody upon the interaction of absorbed enteric antigen with lymphoid tissue in Peyer's patches and, possibly, mesenteric lymph nodes; interference with antigen absorption played little or no role in the observed suppression. These results do not explain the previously reported suppressive effect of primary parenteral immunization on the mucosal immune response to cholera toxin. However, they support the notions that repeated parenteral immunization can evoke avid serum antibody without necessarily stimulating mucosa-associated lymphoid tissue and that such antibody can markedly suppress primary and secondary phases of the local immune response to mucosally applied antigen. Thus, a mechanism is demonstrated by which repeated parenteral immunization may adversely affect efforts to initiate or sustain protective mucosal immune responses.
The mechanisms which control immune responses at mucosal surfaces have not been well defined. A better understanding of such mechanisms should assist efforts to develop more effective ways to stimulate protective mucosal immune responses.
Parenteral immunization with a soluble protein can modify the local immune response to the same antigen when it is applied subsequently at a mucosal surface; both priming and antigenspecific suppressive effects have been described previously (6, 13, 15) . Mucosal priming appears to require an injection route which favors the interaction of injected antigen with immunoglobulin A (IgA) precursors in mucosa-associated lymphoid tissue (15) . In contrast, mucosal suppression follows parenteral immunization by a variety of routes, including those routes which evoke little or no mucosal priming (15) . Although the exact mechanism of such suppression has not been explained, these observations suggest that it is caused by products of the systemic immune response, either cellular or humoral, which reach mucosa-associated lymphoid tissue and modify its responsiveness to mucosally applied antigen. One possibility is that such suppression is due, at least in part, to specific serum antibody raised by the parenteral antigen and is analogous to the well-described suppressive effect of serum antibody on systemic immune responses.
The aims of the present study were to determine whether specific serum antibody suppressed a defined mucosal immune response, the mechanism of such suppression, and the extent to which specific antibody causes the suppression observed after parenteral immunization. The mucosal immune response to cholera toxin was studied; enteric doses of this protein cause distinct primary and secondary type responses, predominantly of the IgA class, in rat intestinal lamina propria (12) . The results show that hyperimmune serum raised by parenterally injected cholera toxoid markedly suppresses both primary and secondary phases of the specific mucosal immune response, whereas serum obtained after a single injection of toxoid is much less effective. They support the notion that avid serum antibody produced by systemic lymphoid tissue can directly suppress the response of mucosa-associated lymphoid tissue to subsequent topical immunization. against phosphate-buffered saline and 0.15 M NaCl, and then concentrated over an XM-50 membrane (Amicon Corp., Lexington, Mass.). Protein contents were determined by absorption at 280 nm (1) .
The effect of 2-mercaptoethanol on purified antitoxin was studied by determining the antitoxin titer after incubating equal volumes of antitoxin and either 0.1 M 2-mercaptoethanol or phosphate-buffered saline for4hat250C.
To precipitate immunoglobulins, purified antitoxin (0.74 mg/mil) was combined with an equal volume of rabbit anti-rat IgG specific for heavy and light chains and containing 3.2 mg of specific antibody per ml (Miles-Yeda Ltd., Rehovot, Israel). The mixture was incubated at 370C for 60 min, and the resulting precipitate was removed by centrifugation at 14,000 x g and 40C for 30 min.
ACC in intestinal lamina propria and thoracic duct lymph. The methods used to identify and count antitoxin-containing cells (ACC) have been described previously (14) . Briefly, thoracic duct lymphocytes (TDL) were obtained by chronic thoracic duct drainage, smeared on slides, and fixed with ethanol. Pieces of intestine were frozen over liquid nitrogen, and sections (thickness, 5 ,m) were cut on a cryostat and fixed in methanol. In both types of preparations, ACC were identified by a fluorescent antibody technique which involved sequential staining with purified cholera toxoid, followed by staining with an immunopurified, fluorescein-conjugated rabbit antitoxin (14) . The frequency of ACC is expressed as the number of ACC collected per hour among TDL or the number per cubic millimeter in the basal region of intestinal lamina propria. To determine geometric means, tissue samples having no detectable ACC were assigned a value of 110 ACC per mm3, which was the lower limit of sensitivity of this scoring method.
Challenge of intestinal segments with cholera toxin. This technique has been described in detail elsewhere (11) . Briefly, two ligated segments of ileum 10 to 14 cm long were prepared in fasted, anesthetized rats. The distal segment was injected with 0.5 ml of isotonic crude cholera toxin, and the proximal segment was injected with 0.9% NaCl. The abdomen was closed. TDL during the enteric booster response was also studied. Rats primed intraduodenally with 12.5 jtg of purified toxin were given 100 p1 of hyperimmune serum i.p. on day 13 and boosted with the same intraduodenal dose of toxin on day 14. TDL were collected by thoracic duct cannulation during the peak of the migration of ACC among TDL (54 to 70 h after boosting [15] ). The geometric mean peak response in rats given immune serum was 113,00 ?} 1.11 ACC per h (n = 5), whereas in rats not given immune serum it was 343,000 .4 1.2 ACC per h (n = 4).
These means differed significantly (P < 0.005). DISCUSSION Numerous studies have described suppression of systemic immune responses by specific serum antibody; these have been summarized in recent reviews (4, 17) . The present study shows that serum antibody induced by parenteral immumzation also suppresses a specific mucosal immune response. Several characteristics of this suppression are virtually identical to those described for suppression of systemic immune responses. The similarities include the following.
(i) Antibody raised by primary parenteral immunization had little or no suppressive effect, whereas hyperimmune serum was highly suppressive (3). (ii) The enhanced suppressive effect of hypenrmmune serum was probably due, at least in part, to increased avidity of specific antibody (18) ; this was suggested by the much greater suppressive effect per microgram of 2-mercaptoethanol-resistant antibody from hyperimmune serum than primary serum. (iii) Hyperimmune serum suppressed the primary antibody response, the development of specific memory, and, somewhat less effectively, the secondary antibody response (17) . And (iv) suppression by hyperimmune serum appeared to involve a dion October 27, 2017 by guest http://iai.asm.org/ Downloaded from rect interaction of antibody with specific antigen (3) since it was overcome by increasing the antigen dose.
Key events in the enteric mucosal immune response include the absorption of enteric antigen (10), its interaction with lymphoid cells in Peyer's patches (8) and, possibly, mesenteric lymph nodes (9) , and the subsequent dissemination via thoracic duct lymph of sensitized, IgA-committed lymphocytes or immunoblasts to other mucosal sites (8, 9, 14) . This study shows that hyperimmune serum antibody exerted its suppressive effect largely on events occurring in Peyer's patches and possibly mesenteric lymph nodes, since it prevented the normal appearance and/or dissemination among TDL of specifically primed lymphocytes during the primary response and of antitoxin-containing immunoblasts during the booster response, but did not interfere with initial events in the absorption of toxin from the gut lumen. Evidence for the latter conclusion is the failure of a suppressive dose of hyperimmune serum to diminish the secretory effect of cholera toxin on the gut mucosa; although other reports have shown that serumderived IgG antibody can traverse gut mucosa and interfere with specific antigen absorption, this occurs only when the serum antibody titer is high (16, 19) . In addition, it is possible that hyperimmune antibody also suppresses the antigen-driven division of specifically sensitized IgA immunoblasts which occurs in enteric lamina propria during the local secondary response (8); this was not examined in the present study.
Despite the similarities cited above, the circumstances under which parenterally induced serum antibody may contribute to the suppression of systemic and mucosal immune responses appear to differ. Highly avid serum antibody produced during a secondary-type systemic immune response appears to have a feedback suppressive effect on that response (4, 5) . Avid antibody also suppresses the primary systemic immune response in passive immunization experiments (3), but such suppression is considered unphysiological since avid antibody is neither present at nor produced by primary parenteral immunization (3) . In contrast, suppression of a mucosal immune response by parenterally induced serum antibody is not a feedback effect, at least not in the strict sense that the product of a response acts to inhibit the response from which it has arisen, since, depending upon the route of injection, parenteral immunization causes little or no mucosal immune response (15) . Instead, such suppression appears to be due to the effect of preexisting, systemically derived serum antibody upon the interaction between mucosa-associated lymphoid tissue and absorbed enteric antigen, a situation reproduced by the present experiments with passively transferred hyperimmune serum. Thus, one circumstance is demonstrated in which preexisting serum antibody may physiologically suppress either the primary or secondary phases of a specific immune response.
The observed effect of parenterally induced serum antibody on the mucosal immune response may have relevance for efforts to immunize against a variety of mucosal infections. It shows one mechanism by which repeated parenteral immunition, which is usually aimed at inducing maximum serum antibody titers, may interfere with the development of mucosal immune responses after natural or planned mucosal exposure to specific or cross-reacting antigens. Such mucosal immune responses may contribute to host protection or prevent asymptomatic shedding of pathogenic agents to the environment or both. To overcome such suppression, a substantially increased local antigenic challenge would be required; the magnitude of this increase may be appreciated by calculating that the hyperimmune serum from twice-immunized donors in this study contained 1,200-fold more suppressive antibody per milliliter than was achieved by transfer of one 50% suppressive dose ofthe same serum to a nonimmune rat, assuming that transfused antibody was distributed in an extracellular volume equalling 20% of body weight.
Finally, this study shows that serum antibody is not substantially responsible for the suppression of the mucosal immune response which appears several weeks after primary parenteral immunization (15) . Other studies in this laboratory, which will be reported elsewhere, have shown that such suppression is predominantly cell mediated, apparently by antigen-specific suppressor T cells.
